Search
for
Sort by
Research 451–480 of 1000+
- Alopecia Areata
- “Structural imprinting” of the cutaneous immune effector function
- Gut Microbiota and Autoimmune Alopecia Areata: Current Insights from the Literature
- INVESTIGATING THE MECHANISMS UNDERLYING THE PATHOGENESIS OF ALOPECIA AREATA
- Biomaterials Functionalized with MSC Secreted Extracellular Vesicles and Soluble Factors for Tissue Regeneration
- Quiescent Tissue Stem Cells Evade Immune Surveillance
- Cachexia and graft-vs.-host-disease-type skin changes in keratin promoter-driven TNF alpha transgenic mice.
- IL-15 in T-Cell Responses and Immunopathogenesis
- Calcitonin gene‐related peptide (CGRP) may award relative protection from interferon‐γ‐induced collapse of human hair follicle immune privilege
- Non-apoptotic role for caspase-7 in hair follicles and the surrounding tissue
- Proteomic Profiling of Central Centrifugal Cicatricial Alopecia Reveals Role of Humoral Immune Response Pathway and Metabolic Dysregulation
- 90 Exploring the therapeutic potential of DHODH inhibitor farudodstat for alopecia areata treatment in a novel ex vivo model of human hair follicle immune privilege collapse
- ISIDLB1777 - A novel ex vivo model of human hair follicle immune privilege collapse reveals the potential of farudodstat, a DHODH inhibitor, as a therapeutic for alopecia areata treatment
- 1432 IL-9/IL-9R signaling as a novel regulator of human hair follicle growth and immune privilege
- Editor's evaluation: Role of distinct fibroblast lineages and immune cells in dermal repair following UV radiation-induced tissue damage
- Activating an adaptive immune response from a hydrogel scaffold imparts regenerative wound healing
- Epidemiology and burden of alopecia areata: a systematic review
- Inactivated COVID-19 Vaccine Induces a Low Humoral Immune Response in a Subset of Dermatological Patients Receiving Immunosuppressants
- Immune therapies for alopecia areata: evidence and new perspectives
- Performance exploration of multi-gene panels of alopecia areata susceptibility and drug-binding targets
- Risk of Autoimmune Skin Diseases Associated With Immune Checkpoint Inhibitors: A Pharmacovigilance Analysis Using the FAERS Database
- The interplay of oxidative stress and immune dysfunction in Hashimoto’s thyroiditis and polycystic ovary syndrome: a comprehensive review
- Leflunomide: an unlikely trigger and mechanistically a beneficial drug for alopecia areata
- IL-15 in alopecia areata: the immune tolerance mechanistic insights and translational perspectives
- Repigmentation Competence in Vitiligo: Integrating Immune, Regulatory, Regenerative, and Microenvironmental Axes
- Bridging psychoneuroimmunology and homeopathy: Modulating the cellular and emotional cascades in refractory alopecia
- Circulating MicroRNA Signatures in Severe Alopecia Areata: Diagnostic Discrimination, Pathway Analysis, and Therapeutic Implications
- Alopecia areata: from immunopathogenesis to emerging therapeutic approaches
- Modulating immune responses in alopecia: therapeutic insights and potential targets of antisense oligonucleotides
- Combined Alopecia Areata and Acquired Hypertrichosis Lanuginosa in Celiac Disease- A Rarest Phenomenon